FDA gives nod to first antipsychotic drug for children

08/22/2007 | Yahoo! · Boston Globe (tiered subscription model), The

The FDA on Wednesday approved the use of Johnson & Johnson's antipsychotic drug Risperdal in children and adolescents with schizophrenia or bipolar disorder. The American Psychiatric Association welcomed the agency's decision, saying it "will encourage federal research agencies to accelerate urgently needed studies of mental disorders in children."

View Full Article in:

Yahoo! · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT